Bridion 200 MG/2 ML vial 2ML
Ended Awarded
- Contract number
- SPE2DB25FXA28
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,727
Award facts
- Contract value 100% obligated
- $48,727.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $48,727.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 ml vials on August 25, 2025, with an ultimate completion date of August 26, 2025. Bridion (sugammadex) is a reversal agent used in anesthesia to rapidly reverse neuromuscular blockade. This non-set-aside delivery order was competitively awarded and represents a specific purchase under AmerisourceBergen's broader pharmaceutical supply relationship with DLA, leveraging the company's extensive federal medical procurement capabilities. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania.
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, medical devices, and healthcare commodities to support military healthcare systems worldwide. AmerisourceBergen's contract portfolio with DLA demonstrates its established position as a critical vendor for federal medical supply needs, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with diverse pharmaceutical products across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FXA28?
SPE2DB25FXA28 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FXA28 worth?
The government has obligated $48,727 on SPE2DB25FXA28.
Is contract SPE2DB25FXA28 an order under another contract?
Yes. SPE2DB25FXA28 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FXA28 competed?
The extent of competition for SPE2DB25FXA28 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award